Regulation of MHC Class II Expression by Interferon-γ Mediated by the Transactivator Gene CIITA
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Major histocompatibility complex (MHC) class II genes are expressed constitutively in only a few cell types, but they can be induced in the majority of them, in particular by interferon-gamma (IFN-gamma). The MHC class II transactivator gene CIITA is defective in a form of primary MHC class II deficiency. Here it is shown that CIITA expression is controlled and induced by IFN-gamma. A functional CIITA gene is necessary for class II induction, and transfection of CIITA is sufficient to activate expression of MHC class II genes in class II-negative cells in the absence of IFN-gamma. CIITA is therefore a general regulator of both inducible and constitutive MHC class II expression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The expression of PD-L1 and MHC II, which may cause exhaustion by binding to T-cell programmed cell death protein 1 (PD-1) and lymphocyte activation gene 3 (LAG-3), respectively, is regulated by tumor interferon (IFN) signaling.”
From Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma (2021) · cites this paper as [27]
Citations
Cites
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
Gorman, C. M., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,830
Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor
Schindler, C., Shuai, K., Prezioso, V. R., & Darnell, J. E. (1992) · Science · doi:10.1126/science.1496401 · Cited by 899
Steimle, V (1993) · Cell · doi:10.1016/0092-8674(93)90685-j · Cited by 864
A Single Phosphotyrosine Residue of Stat91 Required for Gene Activation by Interferon-γ
Shuai, K., Stark, G. R., Kerr, L. M., & Darnell, J. E. (1993) · Science · doi:10.1126/science.7690989 · Cited by 802
Activation of Transcription by IFN-γ: Tyrosine Phosphorylation of a 91-kD DNA Binding Protein
Shuai, K., Schindler, C., Prezioso, V. R., & Darnell, J. E. (1992) · Science · doi:10.1126/science.1281555 · Cited by 775
Collins, T., Korman, A. J., Wake, C. T., Boss, J. M., Kappes, D. J., Fiers, W., Ault, K. A., Gimbrone, M. A., Strominger, J. L., & Pober, J. S. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.15.4917 · Cited by 585
Sequences And Factors: A Guide To Mhc Class-Ii Transcription
Glimcher, L. (1992) · Annual Review of Immunology · doi:10.1146/annurev.immunol.10.1.13 · Cited by 534
Benoist, C., & Mathis, D. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.003341 · Cited by 457
Müller, M., Laxton, C., Briscoe, J., Schindler, C., Improta, T., Darnell, J. E., Stark, G. R., & Kerr, I. M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06106.x · Cited by 411
Detection of a novel human class II HLA antigen
Watson, A. J., DeMars, R., Trowbridge, I. S., & Bach, F. H. (1983) · Nature · doi:10.1038/304358a0 · Cited by 376
Cited by
Items 401–500 of 899
HOBART, M. G., Ramassar, V., Goes, N. B., Urmson, J. R., & Halloran, P. F. (1996) · Transplantation · doi:10.1097/00007890-199612270-00037 · Cited by 31
Characterization of the expressed CIITA allele in the class II MHC transcriptional mutant RJ2.2.5
Brown, J., He, X., Westerheide, S. D., & Boss, J. M. (1995) · Immunogenetics · doi:10.1007/bf00186611 · Cited by 29
The pros and cons of interferons for oncolytic virotherapy
Geoffroy, K., & Bourgeois‐Daigneault, M. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.07.002 · Cited by 32
Immunologic Mechanisms of Multiple Sclerosis
Frohman, E. M., Eagar, T. N., Monson, N. L., Stüve, O., & Karandikar, N. J. (2008) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2008.06.009 · Cited by 29
Camacho-Carvajal, M. M., Klingler, S., Schnappauf, F., Hake, S. B., & Steimle, V. (2003) · International Immunology · doi:10.1093/intimm/dxh010 · Cited by 34
Deng, Q.-W., Yang, H., Yan, F., Wang, H., Xing, F., Zuo, L., & Zhang, H. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1899-8 · Cited by 28
“The MHC class II molecules participant in inducing and activating immune responses, and inflammatory and immune stimuli, particularly cytokines such as IFN-c, enhances the expression of MHC class II genes [46] which are expressed in professional antigen-presenting cells including macrophages, dendritic cells and B cel…”
BackgroundHan, Y., Zhou, Z.-H. L., & Ransohoff, R. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1435 · Cited by 28
Adams, R. C., Carter‐Cusack, D., Llanes, G. T., Hunter, C. R., Vinnakota, J. M., Ruitenberg, M. J., Vukovic, J., Bertolino, P., Chand, K. K., Wixey, J. A., et al. (2023) · Blood · doi:10.1182/blood.2023022040 · Cited by 28
Chikungunya virus persists in joint-associated macrophages and promotes chronic disease in mice
Zarrella, K., Sheridan, R. M., Ware, B. C., Davenport, B., da Silva, M. O. L., Vyshenska, D., Uecker-Martin, A., May, N. A., Fish, E. R., Weiskopf, D., et al. (2026) · Nature Microbiology · doi:10.1038/s41564-026-02303-9 · Cited by 35
Ding, Q., Lu, L., Zhou, X., Zhou, Y., & Chou, K.-Y. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.1210691 · Cited by 27
Control of Expression of Major Histocompatibility Complex Genes in Horse Trophoblast1
Bacon, S. J., Ellis, S. A., & Antczak, D. F. (2002) · Biology of Reproduction · doi:10.1095/biolreprod66.6.1612 · Cited by 27
“This transcriptional silence appears to be caused by the lack of expression of a transacting factor (class II transactivator, or CIITA) responsible for both constitutive and interferon gamma-induced transcription of the MHC class II genes [47, 48].”
BackgroundImmunosuppressive effects of statins
Mach, F. (2002) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(01)00010-1 · Cited by 27
Gyllenberg, A., Asad, S., Piehl, F., Swanberg, M., Padyukov, L., Yserloo, B. V., Rutledge, E. A., McNeney, B., Graham, J., Orho‐Melander, M., et al. (2012) · Genes and Immunity · doi:10.1038/gene.2012.44 · Cited by 27
Murphy, S. P., Holtz, R., Lewandowski, N. M., Tomasi, T. B., & Fuji, H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.3085 · Cited by 27
Rousseau, P., Masternak, K., Krawczyk, M., Reith, W., Dausset, J. B., Carosella, E. D., & Moreau, P. (2003) · Immunology · doi:10.1111/j.1365-2567.2004.01783.x · Cited by 27
pRB is required for interferon-γ-induction of the MHC class II Aβ gene
Zhu, X. S., Pattenden, S. G., & Bremner, R. (1999) · Oncogene · doi:10.1038/sj.onc.1202876 · Cited by 27
“…ectopically expressed in cII-negative cells, mediates cII-induction by IFN-g, and is defective in a subset of patients with bare lymphocyte syndrome, which is characterized by the absence of cII molecules (Chang and Flavell, 1995; Chang et al., 1994; Mach et al., 1996; Steimle et al., 1993, 1994).”
BackgroundSynergistic induction of HLA class I expression by RelA and CIITA
Girdlestone, J. (2000) · Blood · doi:10.1182/blood.v95.12.3804 · Cited by 29
Qi, L., & Ostrand‐Rosenberg, S. (2000) · Traffic · doi:10.1034/j.1600-0854.2000.010207.x · Cited by 28
The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells
Forlani, G., Turrini, F., Ghezzi, S., Tedeschi, A., Poli, G., Accolla, R. S., & Tosi, G. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0853-5 · Cited by 28
Inhibition of antigen presentation by Brucella: many more than many ways
Barrionuevo, P., & Giambartolomei, G. H. (2019) · Microbes and Infection · doi:10.1016/j.micinf.2018.12.004 · Cited by 25
Cioni, B., Jordanova, E. S., Hooijberg, E., van der Linden, R., de Menezes, R. X., Tan, K., Willems, S. M., Elbers, J. B. W., Broeks, A., Bergman, A. M., et al. (2018) · Head & Neck · doi:10.1002/hed.25442 · Cited by 31
Cuthbert, R. J., Wilson, J. M., Scott, N., Coletta, P. L., & Hull, M. A. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.02.005 · Cited by 28
Djidjik, R., Messaoudani, N., Tahiat, A., Meddour, Y., Chaib, S., Atek, A., Khiari, M. E., Benhalla, N. K., Smati, L., Bensenouci, A., et al. (2012) · Allergy Asthma and Clinical Immunology · doi:10.1186/1710-1492-8-14 · Cited by 26
Collinge, M., Pardi, R., & Bender, J. R. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.4.1589 · Cited by 36
Oct-1 Maintains an Intermediate, Stable State of HLA-DRA Promoter Repression in Rb-defective Cells
Osborne, A. R., Zhang, H., Fejér, G., Palubin, K. M., Niesen, M. I., & Blanck, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403118200 · Cited by 27
Inhibitory Effects of IFN-γ on HIV-1 Replication in Latently Infected Cells
Sarol, L. D. C., Imai, K., Asamitsu, K., Tetsuka, T., Barzaga, N. G., & Okamoto, T. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6532 · Cited by 26
Herbrich, S., Chaib, M., Anandhan, S., Andrewes, S. W., Nagarajan, A., Guan, B., Gandhi, N., Gilliam, J., Radovich, M., & Sharma, P. (2026) · Cancer Cell · doi:10.1016/j.ccell.2025.09.011 · Cited by 30
Reduced MHC Class I and II Expression in HPV−Negative vs. HPV−Positive Cervical Cancers
Evans, A. M., Salnikov, M. Y., Tessier, T. M., & Mymryk, J. S. (2022) · Cells · doi:10.3390/cells11233911 · Cited by 32
“conditions, IFNγ stimulates CIITA expression to increase the transcription of MHC class II genes, stimulating antigen presentation by both APCs and non-hematopoietic cells, including epithelial cells [46,52,53].”
BackgroundMolecular Mechanisms of Host–Pathogen Interaction: Entry and Survival of Mycobacteria in Macrophages
Gatfield, J., & Pieters, J. (2003) · Advances in immunology · doi:10.1016/s0065-2776(03)81002-7 · Cited by 26
Lotem, M., Machlenkin, A., Hamburger, T., Nissan, A., Kadouri, L., Frankenburg, S., Gimmon, Z., Elias, O., David, I. B., KUZNETZ, A., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3320 · Cited by 25
Class II transactivator‐induced expression of HLA‐DOβ in HeLa cells
Khalil, H., Deshaies, F., Bellemare‐Pelletier, A., Brunet, A., Faubert, A., Azar, G. A., & Thibodeau, J. (2002) · Tissue Antigens · doi:10.1034/j.1399-0039.2002.600504.x · Cited by 25
Arancibia-Cárcamo, C. V., Osawa, H., Arnett, H. A., Hašková, Z., George, A. J. T., Ono, S. J., Ting, J. P. ‐., & Streilein, J. W. (2004) · European Journal of Immunology · doi:10.1002/eji.200324195 · Cited by 25
Zhou, X., Jiang, Y. Z., Lu, L., Ding, Q., Jiao, Z., Zhou, Y., Xin, L., & Chou, K. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02674.x · Cited by 25
Chen, H., Gilbert, C. A., Hudson, J. A., Bolick, S. C. E., Wright, K. L., & Piskurich, J. F. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.04.026 · Cited by 25
“Introduction The MHC class II transactivator (CIITA) is the primary regulator of both constitutive and inducible expression of MHC class II (MHC II) (Steimle et al., 1993;Steimle et al., 1994;Chang * Corresponding author.”
BackgroundBenson, S. A., & Ernst, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006329 · Cited by 31
Grimm, M. F., Spiecker, M., Caterina, R. D., Shin, W. S., & Liao, J. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110538200 · Cited by 29
Genetic and molecular definition of complementation group D in MHC class II deficiency
Fondanèche, M. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.5.879 · Cited by 25
Han, Y., Zhou, Z.-H. L., & Ransohoff, R. M. (1999) · PubMed · Cited by 25
Saitô, S., Motomura, N., Lou, H., Ramwell, P. W., & Foegh, M. L. (1997) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(97)70084-9 · Cited by 27
Novel roles of the CCR4–NOT complex
Chapat, C., & Corbo, L. (2014) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1254 · Cited by 25
Rodríguez‐Gil, A., Riedlinger, T., Ritter, O., Saul, V. V., & Schmitz, M. L. (2018) · Journal of Visualized Experiments · doi:10.3791/57272 · Cited by 23
Taylor, H. B., Klaeger, S., Clauser, K. R., Sarkizova, S., Weingarten-Gabbay, S., Graham, D. B., Carr, S. A., & Abelin, J. G. (2021) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2021.100116 · Cited by 26
“HLA-II gene transcription is controlled almost entirely by the class II major histocompatibility complex transactivator (CIITA), a non–DNA-binding coactivator that is regulated by multiple different signals, including IFNγ, STAT-1α, and USF-1 (86, 87).”
BackgroundTherapeutic Interventions Targeting Innate Immune Receptors: A Balancing Act
Cao, X., Cordova, A. F., & Li, L. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00716 · Cited by 26
Janowski, A. M., & Sutterwala, F. S. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3566-6_2 · Cited by 24
Martins, I., Sylla, K., Deshayes, F., Lauriol, J., Ghislin, S., Dieu‐Nosjean, M., Viguier, M. A., VEROLA, O., Charron, D. J., Alcaïde‐Loridan, C., et al. (2009) · Melanoma Research · doi:10.1097/cmr.0b013e32832e0bc3 · Cited by 24
Constitutive expression of CIITA directs CD4 T cells to produce Th2 cytokines in the thymus
Patel, D. R., Li, W., Park, J.-S., Sofi, M. H., Gourley, T. S., Hangoc, G., Kaplan, M. H., & Chang, C. (2005) · Cellular Immunology · doi:10.1016/j.cellimm.2005.03.006 · Cited by 26
DNA immunization using a non-viral promoter
Vanniasinkam, T., Reddy, S. T., & Ertl, H. C. J. (2005) · Virology · doi:10.1016/j.virol.2005.08.040 · Cited by 24
Lefebvre, S., Moreau, P., Dausset, J. B., Carosella, E. D., & Paul, P. (1999) · Placenta · doi:10.1053/plac.1998.0380 · Cited by 23
Activation of caprine arthritis-encephalitis virus long terminal repeat by gamma interferon
Tong-Starksen, S., Sepp, T., & PAGTAKHAN, A. S. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.595-599.1996 · Cited by 24
“) and a monoclonal antibody against MHC class II (CA206) (26), respectively.”
BackgroundMethodInfluentialMiller, D. M., Cebulla, C. M., Rahill, B. M., & Sedmak, D. D. (2001) · Seminars in Immunology · doi:10.1006/smim.2001.0291 · Cited by 34
Molecular classification and therapeutics in diffuse large B-cell lymphoma
Shimkus, G., & NONAKA, T. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1124360 · Cited by 32
“EP300 and CREBBP are involved in H3K27 acetylation to promote transcription of tumor suppressor genes such as PRDM1, IRF4, CIITA, CD74, or HLADR, as well as acetylation of BCL6 and p53 which results in inhibition and activation of transcription respectively (Miao et al., 2019).”
BackgroundInfluentialKlein, S. R., Jiang, H., Hossain, M. B., Fan, X., Gumin, J., Dong, A., Alonso, M. M., Gomez‐Manzano, C., & Fueyo-Margareto, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153814 · Cited by 27
Kudriaeva, A. A., Galatenko, V., Maltseva, D. V., Khaustova, N. A., Kuzina, E. S., Tonevitsky, A., Gabibov, A. G., & Belogurov, A. A. (2017) · Molecules · doi:10.3390/molecules22050808 · Cited by 23
“In line with this, analyses of the expression of transcription factors in astrocyte cultures under IFNγ exposure (Figure 3c) revealed that these effects may be caused by JAK-STAT signaling, involving interferon regulatory factor 1 (IRF1), NLRC5 [43], and CIITA [44] (Figure 3d).”
BackgroundHetzel, M., Mucci, A., Blank, P., Nguyen, A. H. H., Schiller, J., Halle, O., Kühnel, M., Billig, S., Meineke, R., Brand, D., et al. (2017) · Blood · doi:10.1182/blood-2017-10-812859 · Cited by 27
Lee, K. S., Kronbichler, A., Vasconcelos, D. F. P., da Silva, F. R. P., Ko, Y., Oh, Y. S., Eisenhut, M., Merkel, P. A., Jayne, D. R. W., Amos, C. I., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8020266 · Cited by 23
Sun, X., Nagahama, Y., Singh, S. K., Kozakai, Y., Nabeshima, H., Fukushima, K., Tanaka, H., Motooka, D., Fukui, E., Vivier, É., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.05.006 · Cited by 28
YASUDA, N., Masuda, K., Tsukui, T., Teng, A., & Ishii, Y. (2009) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2009.08.002 · Cited by 23
“…with major histocompatibilitycomplex(MHC)Imoleculeontheinfected cells (Kuppers and Henney, 1977), while helper T-lymphocyteshaveCD4moleculeandrecognizeextracellularbacteria or soluble antigens presented with MHC II molecule on the surface of antigen presenting cells (Steimle et al., 1994).”
BackgroundMeng, F., Zhen, S., & Song, B. (2017) · Apmis · doi:10.1111/apm.12704 · Cited by 27
Moustakas, A. K., & Papadopoulos, G. K. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10342 · Cited by 23
Gene Expression Profiling of Tuberculous Meningitis Co-infected with HIV
Kumar, G. S. S. (2012) · Journal of Proteomics & Bioinformatics · doi:10.4172/jpb.1000243 · Cited by 25
Willers, J., Häffner, A. C., Zepter, K., Storz, M., Urosevic, M., Burg, G., & Dummer, R. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01339.x · Cited by 22
“The signal transduces through a cascade of phosphorylations and then leads to the activation of CIITA, which in turn induces HLA class II expression (Steimle et al, 1994) and to some extend HLA class I expression as well (Martin et al, 1997).”
BackgroundMolecular analysis of an MHC class II deficiency patient reveals a novel mutation in the RFX5 gene
Peijnenburg, A., van Eggermond, M. C. J. A., den Berg, R. V., Sanal, X. D., Vossen, J. M. J. J., & van den Elsen, P. J. (1999) · Immunogenetics · doi:10.1007/s002510050501 · Cited by 23
“CII-TA fulfills a crucial function in both constitutive and inducible expression of MHC class II. IFN-g has been shown to induce CIITA expression via the JACK-STAT signal transduction pathway (Chang et al. 1994; Lee and Benveniste 1996; Meraz et al. 1996; Muhlethaler-Mottet et al. 1998; Piskurich et al. 1998; Steimle…”
BackgroundLu, Y., Tschickardt, M., Schmidt, B. J., & Blanck, G. (1997) · Immunology and Cell Biology · doi:10.1038/icb.1997.50 · Cited by 23
Retinoblastoma protein expression facilitates chromatin remodeling at the HLA-DRA promoter
Osborne, A. R. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.24.5095 · Cited by 23
Reith, W., Mühlethaler‐Mottet, A., Masternak, K., Villard, J., & Mach, B. (1999) · Microbes and Infection · doi:10.1016/s1286-4579(99)00235-x · Cited by 23
Villard, J., Mühlethaler‐Mottet, A., Bontron, S., Mach, B., & Reith, W. (1999) · International Immunology · doi:10.1093/intimm/11.3.461 · Cited by 22
Ye, Z., Ma, N., Zhao, L., Jiang, Z., & Jiang, Y. (2014) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.12289 · Cited by 22
Mach, B. (1999) · Science · doi:10.1126/science.285.5432.1367 · Cited by 22
Class II MHC genes: a model gene regulatory system with great biologic consequences
Ting, J. P.-Y., & Zhu, X.-S. (1999) · Microbes and Infection · doi:10.1016/s1286-4579(99)00233-6 · Cited by 22
Multiple interactions between BRG1 and MHC class II promoter binding proteins
Mudhasani, R., & Fontes, J. D. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.09.021 · Cited by 22
Liu, A., Takahashi, M., Toba, K., Zheng, Z., Hashimoto, S., Nikkuni, K., Furukawa, T., Koike, T., & Aizawa, Y. (1999) · Hematological Oncology · doi:10.1002/(sici)1099-1069(199912)17:4 · Cited by 22
Szabó, A., Akkouh, I. A., Osete, J. R., de Assis, D. R., Kondratskaya, E., Hughes, T., Ueland, T., Andreassen, O. A., & Djurovic, S. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.11.030 · Cited by 24
Lu, X., Zeng, J., Jia, K., & Yi, M. (2020) · Aquaculture · doi:10.1016/j.aquaculture.2020.736314 · Cited by 22
Uncoupling CD4+ TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma
Draghi, A., Presti, M., Jensen, A. W. P., Chamberlain, C. A., Albieri, B., Rasmussen, A.-C. K., Andersen, M. H., Crowther, M. D., Svane, I. M., & Donia, M. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-3853 · Cited by 22
Ning, B., Tilston-Lünel, A., Simonetti, J., Hicks‐Berthet, J., Matschulat, A. M., Pfefferkorn, R., Spira, A. E., Edwards, M., Mazzilli, S. A., Lenburg, M. E., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02674-5 · Cited by 24
Ahn, D., Kang, S., & Park, H. (2016) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2016.06.004 · Cited by 23
Hashiguchi, A., Hitachi, K., Zhu, W., Tian, J., Tsuchida, K., & Komatsu, S. (2017) · Journal of Proteomics · doi:10.1016/j.jprot.2017.03.025 · Cited by 22
Nigericin Promotes NLRP3-Independent Bacterial Killing in Macrophages
Armstrong, H., Bording‐Jorgensen, M., Chan, R., & Wine, E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02296 · Cited by 23
“This cytokine plays a vital role in induction of the MHC class II complex, which is critical in macrophage defense against viral, protozoal, and some bacterial infections (35).”
BackgroundRegulation of the CD4+ T cell allo-immune response by endothelial cells
Taflin, C., Charron, D. J., Glotz, D., & Mooney, N. (2012) · Human Immunology · doi:10.1016/j.humimm.2012.07.009 · Cited by 25
MHC structure and function − antigen presentation. Part 2
Goldberg, A. C., & Rizzo, L. V. (2015) · Einstein (São Paulo) · doi:10.1590/s1679-45082015rb3123 · Cited by 21
“(5) Proteins involved in the cellular metabolism are synthesized in the endoplasmic reticulum, and when unnecessary or defective (called DRiPs, for Defective Ribosomal Proteins) that is, truncated or altered due to misfolding or erroneous translation(6) are coupled to ubiquitin units.(7-9) The ubiquitin tail transfers…”
BackgroundAcquired STAT4 deficiency as a consequence of cancer chemotherapy
Lupov, I. P., Voiles, L., Han, L., Schwartz, A., Rosa, M. D. L., Oza, K., Pelloso, D., Sahu, R. P., Travers, J. B., Robertson, M. J., et al. (2011) · Blood · doi:10.1182/blood-2011-03-341867 · Cited by 24
Identification of a Phorbol Ester-responsive Element in the Interferon-γ Receptor 1 Chain Gene
Sakamoto, S., & Taniguchi, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105543200 · Cited by 24
Currie, R. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18220 · Cited by 21
Impaired class II transactivator expression in mice lacking interferon regulatory factor-2
Xi, H., Goodwin, B. L., Shepherd, A. T., & Blanck, G. (2001) · Oncogene · doi:10.1038/sj.onc.1204556 · Cited by 27
“CIITA is not only required for constitutive expression of the MHC class II genes, but is also a required mediator of IFN-g induced expression of the MHC class II genes (Steimle et al., 1993, 1994; Chang et al., 1994, 1996; Chin et al., 1994).”
BackgroundInfluentialOno, S. J., & Song, Z. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.11.6396 · Cited by 21
Sims, T. N., Goes, N. B., Ramassar, V., Urmson, J. R., & Halloran, P. F. (1997) · Transplantation · doi:10.1097/00007890-199712270-00005 · Cited by 23
Chang, Y.-J., Ho, T.-Y., Wu, M.-L., Hwang, S., Chiou, T., & Tsai, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076118 · Cited by 20
Polycomb Repressive Complex 2 Confers BRG1 Dependency on the CIITA Locus
Hassan, M. A. E., Tao, Y., Lan, S., & Bremner, R. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403247 · Cited by 20
Young, H. Y., Zucker, P., Flavell, R. A., Jevnikar, A. M., & Singh, B. (2004) · Transplantation · doi:10.1097/01.tp.0000128907.83111.c6 · Cited by 20
Hardy, P., Diallo, T. O., Matte, C., & Descoteaux, A. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03055.x · Cited by 20
Self-Antigen Maintains the Innate Antibacterial Function of Self-Specific CD8 T Cells In Vivo
Dhanji, S., Chow, M., & Teh, H. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.138 · Cited by 20
Abdulkadir, S. A., Casolaro, V., Tai, A. K.-F., Thanos, D., & Ono, S. J. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.64.5.681 · Cited by 20
“A non-DNA binding protein (CIITA) whose expression pattern correlates with class II gene transcription and that strongly transactivates class II genes when expressed in class II-negative cells has also been identified [39, 40 ].”
Human leukocyte antigen expression in sepsis: What have we learned?*
Tschoeke, S. K., & Moldawer, L. L. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000150835.66819.ca · Cited by 19
Ghia, P., Strola, G., Granziero, L., Geuna, M., Guida, G., Sallusto, F., Ruffing, N., Montagna, L., Piccoli, P., Chilosi, M., et al. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200205)32:5<1403::aid-immu1403>3.0.co;2-y · Cited by 271
Class II Transactivator Suppresses Transcription of Thyroid-Specific Genes
Mori-Aoki, A., Pietrarelli, M., Nakazato, M., Caturegli, P., Kohn, L. D., & Suzuki, K. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3769 · Cited by 21
Steroid Receptor Coactivator 1 Links the Steroid and Interferon γ Response Pathways
Tzortzakaki, E., Spilianakis, C. G., Zika, E., Kretsovali, A., & Papamatheakis, J. D. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0439 · Cited by 20
“We studied the effect of overexpressed SRC-1 on the IFN -induced transcription of MHC class II genes (37, 38).”
BackgroundRegulation of MHC Class II Gene Expression
Reith, W., Steimle, V., Durand, B., Kobr, M., & Mach, B. (1995) · Immunobiology · doi:10.1016/s0171-2985(11)80550-4 · Cited by 20
Gao, J., De, B. P., Han, Y., Choudhary, S. K., Ransohoff, R. M., & Banerjee, A. K. (2001) · Journal of Virology · doi:10.1128/jvi.75.3.1124-1131.2001 · Cited by 20
“The IFN-g-induced MHC class II expression is regulated at two distinct levels, namely, JAK/STAT activation and a downstream CIITA expression step (12, 19, 36).”
BackgroundApproved and Future Pharmacotherapy for Multiple Sclerosis
Stüve, O., Cree, B., von Büdingen, H. ‐., Yousef, S., Bowen, J. D., Genain, C. P., Hauser, S. L., Steinman, L., & Zamvil, S. S. (2002) · The Neurologist · doi:10.1097/00127893-200209000-00002 · Cited by 20
Cloning of an interferon regulatory factor 2 isoform with different regulatory ability
Merediz, S. A. K. X. F. N., Schmidt, M., Hoppe, G. J., Alfken, J., Meraro, D., Levi, B. Z., Neubauer, A., & Wittig, B. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.21.4219 · Cited by 25
Metadata
- Authors
- Steimle, V., Siegrist, C.-A., Mottet, A., Lisowska-Grospierre, B., & Mach, B.
- Affiliations
- University of Geneva (CH)
- Jeantet Laboratory of Molecular Genetics, Department of Genetics and Microbiology, University of Geneva Medical School, CH-1211 Geneva 4, Switzerland.
- INSERM U132, Hôpital des Enfants Malades, 15015 Paris, France.
- Venue
- Science
- Published
- 1994-07
- Volume
- 265
- Issue
- 5168
- Pages
- 106-109
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2060320549
- Cited by
- 898
- References
- 29
- Citations by year
- 2026: 33 · 2025: 35 · 2024: 39 · 2023: 49 · 2022: 35 · 2021: 32 · 2020: 25 · 2019: 20 · 2018: 22 · 2017: 19 · 2016: 27 · 2015: 21 · 2014: 18 · 2013: 13 · 2012: 29
- FWCI
- 13.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- MHC class II expression, interferon-gamma, CIITA, MHC class II deficiency, gene expression regulation, transcriptional activation
- MeSH terms
- Histocompatibility Antigens Class II, Cell Line, Chromosome Mapping, Chromosomes, Human, Pair 16, Fibroblasts, Gene Expression Regulation, Genes, MHC Class II, Humans, Interferon-gamma, Models, Genetic, Nuclear Proteins, RNA, Messenger, Transfection, Tumor Cells, Cultured, Trans-Activators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.